{ "ok": true, "cik": "885978", "ticker": "USPH", "name": "U S PHYSICAL THERAPY INC /NV", "filings": [ { "form": "8-K", "filed": "2026-09-21", "items": [ "5.02 Departure or Election of Directors; Appointment of Officers", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/885978/000088597826000057/0000885978-26-000057-index.htm" }, { "form": "8-K", "filed": "2026-08-14", "items": [ "1.01 Entry into a Material Definitive Agreement", "5.02 Departure or Election of Directors; Appointment of Officers", "8.01 Other Events", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/885978/000088597826000052/0000885978-26-000052-index.htm" }, { "form": "8-K", "filed": "2026-08-12", "items": [ "7.01 Regulation FD Disclosure", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/885978/000088597826000048/0000885978-26-000048-index.htm" }, { "form": "8-K", "filed": "2026-08-10", "items": [ "7.01 Regulation FD Disclosure", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/885978/000088597826000045/0000885978-26-000045-index.htm" }, { "form": "10-Q", "filed": "2026-08-07", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/885978/000114036126031825/0001140361-26-031825-index.htm" }, { "form": "8-K", "filed": "2026-08-06", "items": [ "2.02 Results of Operations and Financial Condition", "8.01 Other Events", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/885978/000088597826000042/0000885978-26-000042-index.htm" } ], "events12m": 19, "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0000885978.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=885978" }, "license": "Figures as filed with the SEC. Card text CC BY 4.0, POPS4.", "notAdvice": "Reporting, not investment advice. No price targets, no buy or sell views.", "edgar": "🫧 Edgar looked up U S PHYSICAL THERAPY INC /NV ($USPH). Last filing: 8-K (5.02 Departure or Election of Directors; Appointment of Officers), 2026-09-21. 19 event filings (8-K) in the past twelve months.", "auditor": { "changes": [], "nonReliance": [], "restatedSince": null }, "metrics": { "fiscalYearEnd": "2025-12-31", "revenue": 780990000, "revenueGrowth1y": 0.1633213921307226, "revenueGrowthPerYear": 0.12074095654257655, "yearsOfData": 5, "operatingMargin": 0.11098349530723825, "operatingMarginPrior": 0.09383253021918686, "netMargin": 0.07427111742787999, "operatingCashFlow": 75058000, "capitalSpending": null, "freeCashFlow": null, "researchAndDevelopment": null, "researchShareOfRevenue": null, "cash": 35570000, "longTermDebt": 162459000, "longTermDebtChange": 0.0581649069556891, "revenueHistory": [ { "fiscalYearEnd": "2021-12-31", "revenue": 495022000 }, { "fiscalYearEnd": "2022-12-31", "revenue": 553144000 }, { "fiscalYearEnd": "2023-12-31", "revenue": 604802000 }, { "fiscalYearEnd": "2024-12-31", "revenue": 671345000 }, { "fiscalYearEnd": "2025-12-31", "revenue": 780990000 } ], "totalEquity": 476432000, "totalAssets": 1204010000, "equityRatio": 0.39570435461499487, "returnOnEquity": 0.1217487490344897, "dividendsPaid": 27362000, "payoutRatio": 0.47171795534867683, "dividendPerShare": 1.8, "dividendYearsRising": 5, "dividendCut": false, "priceBased": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown.", "earningsPerShare": 1.42, "sharesOutstanding": 15175000, "bookValuePerShare": 31.395848434925863, "revenuePerShare": 51.465568369028006, "range80": { "low": 703884871.1690899, "high": 1131320030.0052893, "baseline": 892348974.6058443, "n": 4309, "band": "b01" }, "ifPaceHeld": { "low": 703884871.1690899, "high": 1131320030.0052893 } }, "edgarette": "🔖 Exposure: revenue $781.0M (FY2025), total debt $162.5M. Experience: revenue up 16.3% on the year, up 12.1% a year over 4 years; operating margin 11.1%, up from 9.4%. Soundness: equity 39.6% of assets, return on equity 12.2%, payout 47.2% of profit, dividend per share up 5 years running. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $703.9M and $1.1B next year (method v3, set from 4,309 SEC company-years; on a year the method never saw, 83% landed inside). A range, not a forecast. Against peers (10 filers, $50M+ revenue, services-health services): operating margin 11.1% against a -3.3% median; growth 16.3% against 19.2%.", "peers": { "sic": 8000, "sicDescription": "Services-Health Services", "calendarYear": 2025, "minRevenue": 50000000, "depth": 4, "group": "8000", "growth": [ 0.1917, 10 ], "opMargin": [ -0.0327, 10 ], "equityRatio": [ 0.6633, 9 ], "returnOnEquity": [ -0.0246, 8 ] }, "summary": "U S Physical Therapy (USPH) grew revenue 16.3% in FY2025 to $781 million, operating margin 11.1% against a -3.3% median for services-health services, equity 39.6% of assets, and dividend per share up 5 years running. Every figure is from the company’s own annual report filed with the SEC.", "chart": "
U S PHYSICAL THERAPY INC /NV against its own record and its peers
Operating marginPeer median -3.3%11.1%Revenue, on the yearPeer median 19.2%16.3%Equity of assetsPeer median 66.3%39.6%Return on equityPeer median -2.5%12.2%Payout of profit47.2%Gold tick: the median of 8–9 peers with $50M+ revenue in services-health services
", "chartHorizon": "
Handed back now, or kept to compound
Of each dollar of profit47.2% paid out52.8% keptHanded back per share$1.8up 5 years runningGrowth its own profit can fund6.4%retained x return on equityRevenue growth it managed16.3%last year, for comparison

Gold is paid out to shareholders; navy is kept in the business. Retained profit times return on equity is the pace a company can fund from itself. Facts from the filings, not a recommendation.

", "backtest": { "tests": 13, "hits": 13, "rate": 1, "method": "v3", "note": "hindsight: past years, same calibrated range. The range was calibrated on 2022-2024 SEC data, so years in that window are partly in-sample." }, "registry": { "logged": "2026-09-22T14:28:05.267Z", "hash": "2f45a974c1bbfcce", "status": "open" }, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "schema": "pops4.edgarette.card/1", "card": { "summary": "U S Physical Therapy (USPH) grew revenue 16.3% in FY2025 to $781 million, operating margin 11.1% against a -3.3% median for services-health services, equity 39.6% of assets, and dividend per share up 5 years running. Every figure is from the company’s own annual report filed with the SEC.", "exposure": { "fiscalYearEnd": "2025-12-31", "revenue": 780990000, "totalDebt": 162459000, "cash": 35570000 }, "experience": { "revenueGrowth1y": 0.1633213921307226, "revenueGrowthPerYear": 0.12074095654257655, "operatingMargin": 0.11098349530723825, "operatingMarginPrior": 0.09383253021918686, "netMargin": 0.07427111742787999, "freeCashFlow": null }, "soundness": { "equityRatio": 0.39570435461499487, "returnOnEquity": 0.1217487490344897, "payoutRatio": 0.47171795534867683, "dividendPerShare": 1.8, "dividendYearsRising": 5, "dividendCut": false, "note": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown." }, "peers": { "sic": 8000, "sicDescription": "Services-Health Services", "calendarYear": 2025, "minRevenue": 50000000, "depth": 4, "group": "8000", "growth": [ 0.1917, 10 ], "opMargin": [ -0.0327, 10 ], "equityRatio": [ 0.6633, 9 ], "returnOnEquity": [ -0.0246, 8 ] }, "credibility": { "auditedYears": 5, "weight": "reasonable", "standard": "ASOP No. 25", "nonReliance": null, "auditorChange": null }, "range": { "low": 703884871.1690899, "high": 1131320030.0052893, "baseline": 892348974.6058443, "coverage": 0.8, "method": "v3", "basis": "next fiscal year revenue: baseline = revenue x (1 + mean of one-year and three-year pace); range = 10th to 90th percentile of how SEC company-years of the same size band actually turned out", "calibratedOn": { "companyYears": 4309, "sizeBand": "b01" }, "kind": "a calibrated range, not a forecast; no view on the share price", "track": { "backtest": { "tests": 13, "hits": 13, "rate": 1, "method": "v3", "note": "hindsight: past years, same calibrated range. The range was calibrated on 2022-2024 SEC data, so years in that window are partly in-sample." }, "registry": { "logged": "2026-09-22T14:28:05.267Z", "hash": "2f45a974c1bbfcce", "status": "open" }, "scorecard": "https://www.pops4.com/boards/scorecard" } }, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0000885978.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=885978" } }, "definitions": { "operatingMargin": "Operating income divided by revenue.", "netMargin": "Net income divided by revenue.", "freeCashFlow": "Cash from operations minus spending on property and equipment.", "researchShareOfRevenue": "Research and development expense for the year as a share of revenue, both as filed.", "equityRatio": "Shareholders equity as a share of total assets, both as filed. Higher means less of the company is owed to someone else.", "returnOnEquity": "Net income for the year against shareholders equity at year end.", "payoutRatio": "Dividends paid as a share of net income, in the year the cash went out.", "dividendYearsRising": "Consecutive years, counted back from the last on record, in which dividend per share rose. A fall ends the run and is reported as dividendCut.", "revenueGrowthPerYear": "Compound annual growth between the first and latest fiscal years shown.", "credibility": "How much weight a record deserves, in the actuarial sense (ASOP No. 25): more audited years, more weight.", "peers": "Medians of SEC filers with $50M+ revenue in the same industry code (SIC), narrowest group with at least 8 filers, calendar-year figures from SEC XBRL frames.", "backtest": "The same if-the-pace-held arithmetic applied to the company's own past years, scored against what it actually reported next. Hindsight, and labelled so." } }